Back to top
more

Innospec (IOSP)

(Delayed Data from NSDQ)

$121.65 USD

121.65
231,905

+1.65 (1.38%)

Updated Nov 8, 2024 04:00 PM ET

After-Market: $121.70 +0.05 (0.04%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value B Growth C Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 15% (212 out of 250)

Industry: Chemical - Diversified

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Celanese (CE) to Report Q3 Earnings: What's in the Offing?

by Zacks Equity Research

Celanese (CE) is expected to have benefited from its cost actions and contributions of acquisitions amid demand headwinds in certain markets in Q3.

MP Materials (MP) to Report Q3 Earnings: Here's What to Expect

by Zacks Equity Research

MP Materials' (MP) third-quarter 2023 results are likely to reflect weak pricing and higher costs.

Innospec (IOSP) Expected to Beat Earnings Estimates: Should You Buy?

by Zacks Equity Research

Innospec (IOSP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Energy Fuels (UUUU) to Post Q3 Earnings: What's in Store?

by Zacks Equity Research

Energy Fuels' (UUUU) third-quarter 2023 results are likely to reflect the sale of uranium per supply agreements with U.S. nuclear utilities. However, higher costs related to its expansion efforts are expected to hurt the margins.

Alpha Metallurgical (AMR) to Post Q3 Earnings: What's in Store?

by Zacks Equity Research

Alpha Metallurgical's (AMR) third quarter 2023 results are expected to reflect weaker-than-expected shipments and lower realized pricing.

LyondellBasell (LYB) Q3 Earnings and Revenues Surpass Estimates

by Zacks Equity Research

LyondellBasell (LYB) delivered earnings and revenue surprises of 24.24% and 3.22%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?

Why Innospec (IOSP) Could Beat Earnings Estimates Again

by Zacks Equity Research

Innospec (IOSP) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Methanex (MEOH) Q3 Earnings and Revenues Top Estimates

by Zacks Equity Research

Methanex (MEOH) delivered earnings and revenue surprises of 125% and 5.62%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?

Innospec's (IOSP) Earnings Beat Estimates in Q2, Revenues Lag

by Zacks Equity Research

Strong results in Innospec's (IOSP) Oilfield Services unit were partly offset by the weakness in the Performance Chemicals segment in Q2.

Innospec (IOSP) Q2 Earnings Surpass Estimates

by Zacks Equity Research

Innospec (IOSP) delivered earnings and revenue surprises of 0.79% and 3%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

LyondellBasell (LYB) Tops Q2 Earnings Estimates

by Zacks Equity Research

LyondellBasell (LYB) delivered earnings and revenue surprises of 6.55% and 0.87%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Air Products and Chemicals (APD) Q3 Earnings Beat Estimates

by Zacks Equity Research

Air Products and Chemicals (APD) delivered earnings and revenue surprises of 2.41% and 7.20%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Albemarle (ALB) Q2 Earnings Surpass Estimates

by Zacks Equity Research

Albemarle (ALB) delivered earnings and revenue surprises of 71.66% and 5.48%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Linde (LIN) Enters Multiple Agreements With Wanhua in China

by Zacks Equity Research

Linde (LIN) will strike long-term agreements with Wanhua for the supply of industrial gases to its chemical production facilities through the ASUs.

Koppers (KOP) Stock Up 16% in 6 Months: What's Driving It?

by Zacks Equity Research

Koppers (KOP) benefits from execution of its strategic initiatives, actions to raise prices and strong demand from the U.S. utility market.

Here's Why You Should Add Innospec (IOSP) to Your Portfolio

by Zacks Equity Research

Innospec (IOSP) gains on strength in the Oilfield Services unit and actions to drive organic growth across its business portfolio.

Air Products (APD) Selected to Enhance Qatargas' LNG Production

by Zacks Equity Research

Air Products (APD) technology is set to be used by Qatargas in its LNG project, boosting capacity and advancing technology in Qatar's Ras Laffan.

Anindya Barman headshot

4 Diversified Chemical Stocks to Escape Industry Headwinds

by Anindya Barman

Demand softness in certain markets, destocking and raw material cost inflation pose headwinds for the Zacks Chemicals Diversified industry. APD, DD, IOSP and KOP are poised to navigate the industry challenges.

Innospec (IOSP) Q1 Earnings and Revenues Surpass Estimates

by Zacks Equity Research

Innospec (IOSP) delivered earnings and revenue surprises of 15.97% and 1.33%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Olin (OLN) Misses Q1 Earnings and Revenue Estimates

by Zacks Equity Research

Olin (OLN) delivered earnings and revenue surprises of -9.38% and 6.89%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Earnings Preview: Innospec (IOSP) Q1 Earnings Expected to Decline

by Zacks Equity Research

Innospec (IOSP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Innospec (IOSP) Q4 Earnings Lag Estimates

by Zacks Equity Research

Innospec (IOSP) delivered earnings and revenue surprises of -12.41% and 3.15%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Innospec (IOSP) Upgraded to Buy: What Does It Mean for the Stock?

by Zacks Equity Research

Innospec (IOSP) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Chemours (CC) Reports Break-Even Earnings for Q4

by Zacks Equity Research

Chemours (CC) delivered earnings and revenue surprises of -100% and 5.93%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Energy Fuels (UUUU) Gets $18.5M Government Uranium Contract

by Zacks Equity Research

Energy Fuels (UUUU) will sell $18.5 million of natural uranium to the U.S. National Nuclear Security Administration, which will help establish a federal reserve of domestically produced material.